Found 8 matching trials
Safety, Tolerability and Pharmacokinetics of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy PHASE1 Quisinostat besides its own efficacy, which can potentially lead to better ...
Show More Location
Russian Oncological Research Center n.a. N. N. Blokhin RAMS
Learn More & Join Trial
Adjuvant Quisinostat in High-Risk Uveal Melanoma PHASE2 The purpose of this study is to see if giving participants quisinostat will...
Show More Location
University of Miami
Learn More & Join Trial
Phase 0 With Expansion Phase Clinical Trial of Quisinostat Plus Radiotherapy in Newly-diagnosed and Recurrent Grade 4 IDH-Wildtype Glioblastomas EARLY_PHASE1 This is an open-label, multi-center Phase 0/1b study that will enroll up to...
Show More Status
Active Not Recruiting
Location
St. Joseph's Hospital and Medical Center
Learn More & Join Trial
A Dose Escalation Study of the Histone Deacetylase Inhibitor (HDACi) JNJ 26481585 in Combination With VELCADE (Bortezomib) and Dexamethasone for Patients With Relapsed Multiple Myeloma PHASE1 The purpose of this study is to evaluate the safety and tolerability and to...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Efficacy of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy PHASE2 This is a multicenter, open-label study of safety and efficacy of Quisinost...
Show More Location
Federal State budget Scientific Agency "Russian Oncological Research Center n.a. N.N. Blokhin"
Learn More & Join Trial
A Study of the Histone-deacetylase Inhibitor JNJ-26481585 in Patients With Advanced or Refractory Leukemia or Myelodysplastic Syndrome PHASE1 The purpose of this study is to explore the safety, pharmacokinetic (what t...
Show More Location
Multiple Locations
Learn More & Join Trial
A Safety and Dose-finding Study of JNJ-26481585 for Patients With Advanced Solid Malignancies and Lymphoma. PHASE1 The purpose of this study is to assess the safety of the drug (JNJ-24681585...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of the Histone Deacetylase Inhibitor (HDACi) Quisinostat (JNJ-26481585) in Patients With Previously Treated Stage Ib-IVa Cutaneous T-cell Lymphoma PHASE2 The purpose of this study is to determine the overall cutaneous response ra...
Show More Location
Multiple Locations
Learn More & Join Trial